RED HOT Contributors

 

STAT Plus: Marathon Pharma is the latest drug maker to leave the industry trade group

0
CREDIT: This post was originally published on this site

N

ow that Marathon Pharmaceuticals has sold its Duchenne muscular dystrophy drug, the company unceremoniously withdrew from a big industry trade group, which began a review of its membership criteria two months ago after Marathon caused a stink over its pricing.

The drug maker sent a note on Thursday night to the Pharmaceutical Research & Manufacturers of America saying it is “discontinuing its membership in all relevant trade associations” after closing a deal earlier in the day to sell its drug to PTC Therapeutics. This is the second drug maker to leave the trade group. Earlier this month, Mallinckrodt resigned as the trade group proceeded with its review.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

About

We Support OUR Contributors

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast